Latest / The BioHub - by Avetix
Episode 156 - Rafiq Hasan - CEO of Complement Therapeutics
We sit down with Rafiq Hasan, co-founder & CEO of Complement Therapeutics, at their London offices to unpack a milestone-loaded past 6 months.
Rafiq shares the company's thesis, based on research from Manchester university, and how in practice they are targeting the complement system.
We also dig into a landmark moment for the company - the recent dosing of patients in OPTI-GAIN, their Phase 1/2 clinical trial targeting Geographic Atrophy, a leading cause of irreversible vision loss.
Another topic of discussion centers around what it's took to build a biotech from the ground up over the past…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.